Market Overview Announces Investment Opinion on Amerityre Corporation, NCR Corporation, Sunesis Pharmaceuticals Inc., Cyclacel Pharmaceuticals Inc. and Christopher & Banks Corp.


PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at

At PicksThatMove, our team scours the technical and financials of hundreds of companies to identify those stocks showing the greatest potential for growth.

The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of

Amerityre Corporation (NASDAQ: AMTY), $0.371, +0.113, 43.85%, focuses on research and development of technologies related to the formulation of polyurethane compounds and is a leading manufacturer of producing tires from polyurethane. The company is surging in volume today, trading near its high of 0.419 touching down on a low of 0.25. AMTY announced that it has secured sales to a major OEM manufacturer of track systems for Utility Terrain Vehicles. The track system is the latest technology for use in the four wheel utility market.

NCR Corporation (NYSE: NCR), $10.70, +0.91, 9.30%, offers technology and services which assist businesses in interacting, connecting and relating with their customers. NCR Corporation expanded its network of DVD-rental kiosks by acquiring DVDPlay, which operates approximately 1,300 kiosks in the U.S. and Canada. NCR's kiosks hold more than 900 DVD titles and access to other BLOCKBUSTER Express kiosks for DVD renting. NCR kiosks are also digital download-ready. Consumers will be able to download movies from the kiosks to portable memory cards. NCR hit a high today of 11.05 with 7.4 million shares traded.

Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), $1.98, +0.59, 42.46%, reached a high today of 2.43, beating out its 52 week-high of 1.84. SNSS touched down on a low of the day at 1.32, with 61 million shares traded. SNSS reported positive data from two Phase 2 clinical trials of its leading drug, voreloxin. The drug is aimed for treatment in patients with acute myeloid leukemia and is beneficial when used alone or in combination with chemotherapy in patients. Skymark Research and Emerging Stock Report have initiated independent coverage on the company.

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC), $1.42, +0.43, 43.45%, is surging high in volume today with over a 43% gain. Earlier this month Cyclacel announced the 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, in elderly patients with acute myeloid leukemia. Skymark Research, an independent investment research company, announced that it has initiated coverage on Cyclacel. Cyclacel is a biopharmaceutical company focusing its research and discovery on cell cycle biology.

Christopher & Banks Corp. (NYSE: CBK), $7.75, +1.73, 28.74%, runs a chain of retail stores selling women’s apparel throughout the United States. CBK opened at the day’s low of 6.81 and it went up over a 1.00 hitting a high of 7.96, with heavy volume. CBK released its anticipated third quarter financial results indicating expected revenue of $132 million, with same-store sales for the quarter declining by 8.4%. Earnings per diluted share are expected to be between $0.19 and $0.21, which assumes an anticipated effective tax rate for the third quarter of 22%. The company will hold an earnings call on January 6, 2010.

About is an independent electronic publication that provides information on selected publicly traded companies. is not a registered investment advisor or broker-dealer.’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please follow us on Twitter and Facebook for further investment updates. We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Nick Hunter, RIA, of PicksThatMove is a member of the National Association of Securities Dealers, CRD number 2022366

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at